These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7860716)

  • 1. Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats.
    Ruuls SR; Bauer J; Sontrop K; Huitinga I; 't Hart BA; Dijkstra CD
    J Neuroimmunol; 1995 Feb; 56(2):207-17. PubMed ID: 7860716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system.
    Körner H; Lemckert FA; Chaudhri G; Etteldorf S; Sedgwick JD
    Eur J Immunol; 1997 Aug; 27(8):1973-81. PubMed ID: 9295034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic relapsing experimental allergic encephalomyelitis in the Lewis rat.
    Feurer C; Prentice DE; Cammisuli S
    J Neuroimmunol; 1985 Dec; 10(2):159-66. PubMed ID: 3877741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhesus diploid rabies vaccine (adsorbed): neurological safety in guinea pigs and Lewis rats.
    Levenbook IS; Elisberg BL; Driscoll BF
    Vaccine; 1986 Dec; 4(4):225-7. PubMed ID: 2432737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perforin and tumor necrosis factor alpha in the pathogenesis of experimental allergic encephalomyelitis: comparison of autoantigen induced and transferred disease in Lewis rats.
    Held W; Meyermann R; Qin Y; Mueller C
    J Autoimmun; 1993 Jun; 6(3):311-22. PubMed ID: 7691064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of the clinical and histopathologic expression of experimental allergic encephalomyelitis by the vasoactive amine antagonist cyproheptadine.
    Waxman FJ; Taguiam JM; Whitacre CC
    Cell Immunol; 1984 Apr; 85(1):82-93. PubMed ID: 6201289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
    Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
    Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic permeability of the central nervous system to mononuclear cells in experimental allergic encephalomyelitis in the Lewis rat.
    Stohl W; Gonatas NK
    J Immunol; 1978 Sep; 121(3):844-50. PubMed ID: 308523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propentofylline and iloprost suppress the production of TNF-alpha by macrophages but fail to ameliorate experimental autoimmune encephalomyelitis in Lewis rats.
    Jung S; Donhauser T; Toyka KV; Hartung HP
    J Autoimmun; 1997 Dec; 10(6):519-29. PubMed ID: 9451591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis.
    Gold DP; Schroder K; Powell HC; Kelly CJ
    Eur J Immunol; 1997 Nov; 27(11):2863-9. PubMed ID: 9394811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cells in brains during experimental allergic encephalomyelitis in Lewis rats.
    Bø L; Olsson T; Nyland H; Krüger PG; Taule A; Mørk S
    J Neurol Sci; 1991 Oct; 105(2):135-42. PubMed ID: 1757789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased apoptosis of T lymphocytes and macrophages in the central and peripheral nervous systems of Lewis rats with experimental autoimmune encephalomyelitis treated with dexamethasone.
    Nguyen KB; McCombe PA; Pender MP
    J Neuropathol Exp Neurol; 1997 Jan; 56(1):58-69. PubMed ID: 8990129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of experimental autoimmune encephalomyelitis in Lewis rats treated with fucoidan.
    Kim H; Moon C; Park EJ; Jee Y; Ahn M; Wie MB; Shin T
    Phytother Res; 2010 Mar; 24(3):399-403. PubMed ID: 19655293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of experimental allergic encephalomyelitis by alpha 2-macroglobulin.
    Hunter N; Weston KM; Bowern NA
    Immunology; 1991 May; 73(1):58-63. PubMed ID: 1710603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune effector cells. IV. Induction of experimental allergic encephalomyelitis in Lewis rats without adjuvant.
    Holda JH; Silberg D; Swanborg RH
    J Immunol; 1983 Feb; 130(2):732-4. PubMed ID: 6184402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.
    Jung S; Toyka K; Hartung HP
    Eur J Immunol; 1995 May; 25(5):1391-8. PubMed ID: 7539758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human tumor necrosis factor-alpha augments experimental allergic encephalomyelitis in rats.
    Kuroda Y; Shimamoto Y
    J Neuroimmunol; 1991 Nov; 34(2-3):159-64. PubMed ID: 1918322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock proteins and experimental autoimmune encephalomyelitis (EAE): I. Immunization with a peptide of the myelin protein 2',3' cyclic nucleotide 3' phosphodiesterase that is cross-reactive with a heat shock protein alters the course of EAE.
    Birnbaum G; Kotilinek L; Schlievert P; Clark HB; Trotter J; Horvath E; Gao E; Cox M; Braun PE
    J Neurosci Res; 1996 May; 44(4):381-96. PubMed ID: 8739158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of circulating and cell-bound antibodies in experimental allergic encephalomyelitis.
    Gonatas NK; Gonatas JO; Stieber A; Lisak R; Suzuki K; Martenson RE
    Am J Pathol; 1974 Sep; 76(3):529-48. PubMed ID: 4547331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors.
    Ruuls SR; Van Der Linden S; Sontrop K; Huitinga I; Dijkstra CD
    Clin Exp Immunol; 1996 Mar; 103(3):467-74. PubMed ID: 8608648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.